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Abstract
Background: The most common malignant salivary gland tumors that affect both adult and children is
mucoepidermoid carcinoma. It usually affects both minor and major salivary glands but parotid gland is considering
the most common site in which this tumor arises. CD44, a trans-membrane glycoprotein, is an adhesion molecule
of cell surface that play a role in the connections between cell-cell and cell-matrix. Many malignant tumors express
high levels of CD44, thus, CD44 may be used as an indicator of aggressive behavior of some human malignancy.
We evaluate CD44 expression in different grades of mucoepidermoid carcinoma and determine whether expression
of CD44 can be used to predict tumor aggressiveness.
Methods: Fifteen cases of mucoepidermoid carcinoma were retrieved from the oral pathology archives and
grouped according to the histological grade as well as the clinical behavior regarding metastases
and/or recurrence. Tissue sections were immunohistochemically stained for CD44. CD44 staining was scored for
intensity and proportion of cells stained.
Results: A higher proportion of high-grade tumor tissues showed moderate or strong CD44 staining compared
to low-grade tumors. Additionally, CD44 expression was stronger in tumors from patients with recurrences or
metastases, but theses differences were not statistically significant.
Conclusion: Our result showed that mucoepidermoid carcinomas are immunohistochemistry positive to CD44
compare to normal. A trend of CD44 expression associated with different histological grading and aggressive
behavior of this tumor.
Keywords: Salivary gland tumor, Mucoepidermoid carcinoma, CD44, Adhesion molecules
Background
The most common type of malignant salivary gland
tumor affecting both adults and children is mucoepider-
moid carcinoma (MEC). It usually affects both minor
and major salivary glands, but the parotid gland is consid-
ered the most common site at which this tumor arises and
usually has better prognosis than other major salivary
glands. Histologically, MECs are composed of epidermoid,
mucous, and intermediate cells and are graded low, inter-
mediate, or high according to one of the following grading
systems: the modified Healey system, the Armed Forces
Institute of Pathology (AFIP) grading system, and the
Brandwien system. These grading schemes for MEC are
important to determine tumor progression and patient
management [1, 2].
CD44, a trans-membrane glycoprotein, is a cell surface
adhesion molecule that plays a role in cell-cell and cell-
matrix interactions. Many malignant tumors, such as
head and neck, breast, and prostate cancer, express high
levels of CD44 or its variants [3–5]. Thus, CD44 may be
used as an indicator of aggressive behavior of some
human malignancies. However, the role of CD44 in MEC
remains unclear.
CD44 is encoded by a single gene located on the short
arm of chromosome 11 in humans and is required to
maintain complex tissue morphology. CD44 exists in a
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standard form (CD44s) and 10 distinct isoforms (CD44v)
that arise from alternative splicing of mRNA and further
posttranslational glycosylation [6]. The protein is com-
posed of three domains: extracellular, transmembrane,
and intracellular. Its extracellular portion contains the N-
terminus, which primarily binds to the ligand hyaluronan
(HA), where their interaction promotes signal transduc-
tion, regulates matrix assembly and cell migration, and
maintains proliferation and differentiation of cancer stem
cells (CSCs) [7–9]. CD44 is expressed in many normal
cells such as lymphocytes, and epithelial and endothelial
cells during hematopoiesis, embryonic development and
wound healing [5].
Classical CD44 molecules are intimately involved in
the pathogenesis of malignancies such as esophageal
cancer, breast cancer, gastric cancer, and prostate cancer
[4, 5, 7] CD44 has also been reported as a marker of
CSCs in prostate, breast, and head and neck cancer and
its expression in these tumors is associated with poor
prognosis and aggressive behavior [4, 10, 11]. CSCs are
stem-like cells that have the potential to regenerate a
tumor mass and maintain their renewal ability. Given
the important functions of CD44 in cell-cell and cell-
matrix interactions, CSCs are usually postulated to play
a vital role in cancer metastasis and aggressiveness.
MEC comprises 12–29 % of malignant tumors [1]. The
histogenesis of salivary gland mucoepidermoid carcinoma
still remains a controversial topic. Some believe that this
tumor originates from myoepithelial cells, the excretory or
the intercalated duct cells, or intermediate cells. Histo-
logically, MECs are classified as low, intermediate, or high
grade on the basis of the following features: the presence
of cellular differentiation, cystic spaces, proportion of
mucous cells, growth pattern, type of invasion, and
cytological atypia. Many MECs were found to be posi-
tive for translocation of cyclic AMP response element-
binding protein (CREB)-regulated transcription coactivator
(CRTC1-MAML2) t(11;19) [12]. The prognosis of MEC
depends mostly on the histological grade, since high-grade
MEC is a highly aggressive tumor, while its low-grade vari-
ant usually demonstrates a more benign nature.
The treatment of choice in MEC is surgical resection.
Whether adjunctive postoperative radiotherapy and/or
chemotherapy improve the patient survival rate is not
known because of the absence of a systemic analysis of
published studies. Metastasis, which can affect patient sur-
vival, is a complex process and is not fully understood.
We hypothesized that the destruction of adhesions by
CD44 provides more free malignant cells that might act to
facilitate recurrence and/or metastasis of MECs.
Methods
Tissues from 15 patients with a specific diagnosis of
mucoepidermoid carcinoma of the salivary gland from
Mansoura University, Egypt, were collected from 2001
to 2006. The Ethics Committee of Mansoura University
Hospital authorized the collection of specimens, and
follow-up data was obtained from patients’ pathology
reports. We followed the guidelines of human subjects
in the Declaration of Helsinki. The hematoxylin and eosin-
stained slides were reviewed and graded in accordance
with the Brandwien grading system [13].
Immunohistochemical staining of tissue sections was
conducted as follows. After dewaxing and hydration of
the tissue sections, antigen retrieval was performed by
microwaving in citrate buffer (10 mM citric acid,
pH 6.0). Tissue sections were then blocked in 2 % bovine
serum and incubated in a moist chamber at 4 °C over-
night with anti-CD44 Std-antibody (Thermo Scientific,
Clone 156-3C11). The slides were incubated for 10 min
at 37 °C with a secondary biotinylated anti-mouse anti-
body and then incubated with streptavidin-HRP. Speci-
mens were developed with DAB and the nucleus was
counterstained with hematoxylin. The sections were
photographed under a microscope and analyzed by two
pathologists.
Semiquantitative evaluation was performed in tumor
tissue using the Allred immunostaining scoring system
[14]. The staining intensity was scored as 0 (none), 1
(mild), 2 (moderate), or 3 (strong); and the propor-
tion of stained cells was score as 0 (none), 1 (>0–1 %), 2
(≥1–10 %), 3 (>10–33 %), 4 (>33–66 %) and 5 (>66–
100 %). The sum of the proportion score and the intensity
score was calculated to obtain a total score that ranged
from 0 to 8. The significance of the differences between
groups was evaluated using an unpaired Student t
test (GraphPad Software, La Jolla, California, United
States). P values of <0.05 were considered statistically
significant.
Results
The mean age of the 15 patients was 49.7 years (range:
21–70). There were nine (60 %) female and six (40 %)
male patients. There were 13 cases from the parotid
gland and two from the submandibular gland. Five cases
(33.3 %) were classified as low-grade, two cases (13.3 %)
as intermediate-grade and eight (53.3 %) as high-grade
tumors. Regional lymph node metastasis was noted in
eight cases (53.3 %), distant metastases were present in
four cases (26.7 %), and local recurrence was found in
four patients (26.7 %). Immunohistochemical tissue
staining was performed to detect the expression of
CD44 in normal salivary glands and in MEC tissue. Rep-
resentative results are shown in Fig. 1. CD44 expression
was found in 13 cases (86.7 %) and considered weak in
two (13.3 %), moderate in three (20 %) and strong in
eight (53.3 %) cases. Membranous staining was seen in
mucous, intermediate, myoepithelial and epidermoid
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cells in tumor tissues while in normal tissue, staining
was positive in lymphocytes, while weak focal cytoplas-
mic staining was observed in ductal cells. Data on CD44
expression, histological grade, lymph node involvement,
recurrence and metastasis are summarized in Table 1.
High-grade tumors showed moderate to strong CD44
expression (87.5 %) more frequently than did low-grade
tumors (40 %), but this difference was not statistically
significant (P =0.2108). CD44 expression was strong in
tumors of patients who presented local recurrence and
metastasis around 75 % in each group, although this dif-
ference in expression compared to tumors of patients
who did not have local recurrence or metastasis is failed
to meet statistical significant (P = 0.5327, 0.2839). No
correlation was found between CD44 expression and
lymph node involvement (P = 0.3599; P < 0.05). Survival
data were not available and not included in this study.
Discussion
Mucoepidermoid carcinoma shows widely diverse bio-
logical behaviors. High-grade MEC is a highly aggressive
tumor, whereas low-grade MEC shows a more benign
nature [15]. In our study, MEC was more frequent in
the parotid gland of female patients, primarily between
the third and sixth decades of life. Molecular alterations
associated with histologic and clinical behavior of this
tumor are still not clearly understood, and therefore
additional studies are necessary. In this study, we exam-
ined the expression of CD44 in normal salivary gland
and in MEC tissues of different histological grades.
Fig. 1 Immunohistochemistry for CD44 in Mucoepidermoid carcinomas. a Normal salivary glands showed weak cytoplasmic stain in ductal
epithelium and no immunoreactivity is seen in acinic cells. b No or mild CD44 expression was observed in the membrane of mucoepidermoid
carcinoma cells (low grade type). c, d CD44 expression was strongly expressed in the membrane of the mucoepidermoid carcinoma cells
(intermediate and high grade type)
Table 1 CD44 expression according to histological grade of mucoepidermoid carcinoma cases
Location CD44 Expression
*P/S 13/2 Negative (%) Weak (%) Moderate (%) Strong (%)
Grade
Low grade 5/0 2/5 (40) 1/5 (20) 1/5 (20) 1/5 (20)
Intermediate grade 1/1 0/2 (0) 0/2 (0) 1/2 (50) 1/2 (50)
High grade 7/1 0/8 (0) 1/8 (12.5) 1/8 (12.5) 6/8 (75)
Lymph node
Positive 8/15 7/2 0/8 (0) 1/8 (12.5) 2/8 (25) 5/8 (62.5)
Negative 7/15 7/0 2/7 (28.6) 1/7 (14.3) 1/7 (14.3) 3/7 (42.85)
Metastasis 4/15 4/0 0/4 (0) 1/4 (25) 0/4 (0) 3/4 (75)
Recurrence 4/15 3/1 0/4 (0) 0/4 (0) 1/4 (25) 3/4 (75)
*P; Parotid gland. S; Submandibular gland
Binmadi et al. Head & Face Medicine  (2016) 12:8 Page 3 of 5
CD44 is an adhesion molecule and a marker of CSCs
that is expressed in several normal and tumor tissues.
Metastasis and aggressiveness have been correlated with
CD44 expression in breast cancer and renal cell car-
cinoma [5]. Our immunohistochemistry analysis showed
that CD44 expression is substantially upregulated in
MEC tissues compared with adjacent normal tissue, in-
dicating that CD44 may contribute to tumorigenicity in
MEC, but we failed to observe statistically significant dif-
ferences in CD44 expression in recurring and metasta-
sized MEC as compared to other MEC. Chang et al.
found that the expression of HA but not its receptors
CD44 and the hyaluronan receptor for endocytosis
(HARE) are associated with MEC metastasis and lymph
node involvement [16]. Xing et al. found that HA and
CD44 are expressed in most malignant salivary gland
tumors including MEC [17].
Analysis of the expression of CD44 and its variant
isoforms in salivary gland tumors has yielded different
results depending on the type of tumor studied. Fok et
al. showed low expression of CD44 in salivary gland tu-
mors (pleomorphic adenoma, polymorphous low grade
adenocarcinoma and adenoid cystic carcinoma) com-
pared with normal tissue [18]. This result is consistent
with our data showing that low expression of CD44 is
associated with less aggressive tumors. Wein et al. re-
ported expression of HA and its associated receptors
CD44 and HARE in mucoepidermoid carcinoma [19].
Other studies using qPCR support these findings; CD44
was overexpressed in the tumors from salivary glands
compared with normal salivary glands [20]. CD44v3 and
v6 variants are widely expressed by the myoepithelial
cells of salivary gland tumors and are correlated with the
ability to self-renew [21].
We noted a tendency of higher CD44 expression in
high-grade tumors compared to low grade, so it can
serve as tumor behavior indicator. Since the numbers of
cases of each grade of mucoepidermoid carcinoma in-
vestigated in this study were relatively small, the rela-
tionship between clinicopathological factors and CD44
expression levels in each grade of carcinomas could not
be clarified, however, we found that the CD44 staining is
varies among different stage of MEC. Another limitation
of our study is the incompleteness of patient records, in-
cluding lack of stage and survival data, which could limit
our results.
The mechanism by which a tumor cell invades the sur-
rounding structure is poorly understood in MEC. Several
studies suggest that extracellular matrix composition
might regulate cell invasion, and that HA and CD44
might facilitate the invasive behavior of tumors [7]. In
conclusion, increased expression of CD44 might play an
important role in increasing the potential for tumorigen-
esis; as well as, we found a trend from our results that
the expression of this molecule can be employed as a
predictor of tumor behavior and recurrence but further
studies with other markers and bigger samples may be
more helpful in this regard.
Conclusion
CD44 showed to be expressed by neoplastic cells in
MEC like other type of cancer. This expression was not
found to correlate with the lymph node involvement of
tumor. We observed that CD44 expression was associ-
ated with four metastasis cases and four recurrent cases
but no significant relation was found and this indicated
that CD44 is not a prognostic indicator. In other hand,
our study showed a differential staining of CD44 in
MEC in different histological grades and this may be an
interesting finding that should be explored further in
other study with actual correlation with prognosis.
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